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Chain lengthAbstract Sphingolipid research has surged in the past two decades and has produced a wide vari-
ety of evidence supporting the role of this class of molecules in mediating cellular growth, differ-
entiation, senescence, and apoptosis. Ceramides are a subgroup of sphingolipids (SLs) that are
directly involved in the process of initiation of apoptosis. We, and others, have recently shown that
ceramides are capable of the formation of protein-permeable channels in mitochondrial outer mem-
branes under physiological conditions. These pores are indeed good candidates for the pathway of
release of pro-apoptotic proteins from the mitochondrial intermembrane space (IMS) into the cyto-
sol to initiate intrinsic apoptosis. Here, we review recent ﬁndings on the regulation of ceramide
channel formation and disassembly, highlighting possible implications on the initiation of the
intrinsic apoptotic pathway.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf ofKing SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Whether a cell proliferates or perishes requires a complex set of
cellular decisions that depend on the environment and its
physical and nutritional states. Signaling in cells is regulated
optimally through a wide array of macromolecules and mes-
sengers that control the fate of the cell creating many inter-
twined networks of regulators and effectors. Until recently,
SLs were merely considered structural components of cellular
membranes. We now know of a plethora of functions these
molecules perform in cell signaling, stress and death
(Hannun, 1996; Saba et al., 1996; Chalfant et al., 2001;
Jenkins and Hannun, 2001). Multiple novel agents that modu-
late SL metabolism have been studied and at least in one
instance applied therapeutically for cancer treatment (Adan-
Gokbulut et al., 2013). Ceramide (Cer), is responsible for sev-
eral intracellular signals and is considered the parent SL
Figure 1 The basic structure of sphingolipids. SLs have a So
backbone (orange) that is N-acylated with fatty acids of a variety
of chain lengths (blue). The C-1 hydroxyl can be as simple as a
hydrogen atom (in ceramides) or as complex as multiple carbohy-
drate subunits in cerebrosides and gangliosides. The trans double
bond at C-4 is characteristic of Cer and when it is saturated the
molecule is DHCer.
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et al., 1996; Lee et al., 1996).
Ceramides are a family of lipids with a sphingosine (So)
backbone N-acylated with a variety of fatty acids, creating a
diverse group of molecules (Fig. 1). They are involved in cell
signaling in various contexts (Hannun, 1996; Saba et al.,
1996; Jayadev and Hannun, 1996; Lee et al., 1996;
Hayakawa et al., 1996; Yoon et al., 2002; Shin et al., 2002;
Obeid et al., 1993). In this review we focus on one aspect of
Cer cell signaling: the regulation of cell death by Cer channel
formation in the outer membranes of mitochondria (Siskind
et al., 2002). In addition to this pathway of protein release,
there are many proposed pathways to explain how mitochon-
drial IMS proteins are discharged from mitochondria: the
opening of the permeability transition pore (Crompton,
1999; Crompton et al., 1999); the oligomerization of Bax
monomers to achieve channel activity (Antonsson, 2001;
Antonsson et al., 2000, 2001; Saito et al., 2000); the opening
of the mitochondrial apoptosis-induced channels (Pavlov
et al., 2001); the interactions of BH3/Bax/cardiolipin
(Kuwana et al., 2002), and the interactions between Bax and
Cer (Belaud-Rotureau et al., 2000). Regardless of the pathway,
it is clear that Bcl-2 (B cell CLL/lymphoma) family proteins
play a central role in the regulation of mitochondrial
permeability. Here, we review the effects of these proteins,
and other metabolites, on Cer channel formation and
disassembly highlighting possible implications on the onset
of intrinsic apoptosis.
2. Ceramide
Cer is a condensation product of the amino alcohol So and a
fatty acid in an acylation reaction. The range of acylation is
wide, creating ceramides that contain fatty acids varying from
6 to 34 or even more carbons. D-erythro-N-palmitoyl-
sphingosine (C16-Cer) is an example of one of the naturally
occurring forms of Cer (Fig. 1). Another key aspect of the
Cer molecule is the presence of a 4,5-trans double bond that
clearly has a profound impact on the biophysical characteris-
tics of Cer and on cell survival pathways, as will be presented
later.
Of the various roles of Cer inside cells, the ability to induce
apoptosis is the clearest. Ceramides have been shown to induce
apoptosis directly and indirectly (Saba et al., 1996; Obeid
et al., 1993; Linardic et al., 1996; Danial and Korsmeyer,
2004; Wiesner and Dawson, 1996a,b). MCF7 breast cancer
cells experienced mitochondrial outer membrane permeabiliza-
tion and apoptosis when bacterial sphingomyelinase (a Cer-
generating enzyme) was targeted to mitochondria and Cer
was generated speciﬁcally in mitochondria (Birbes et al.,
2001). When bacterial sphingomyelinase was targeted to other
organelles, apoptosis and mitochondrial permeabilization did
not occur (Hannun et al., 2001). In leukemia cells, Cer levels
were increased signiﬁcantly upon the addition of the
chemotherapeutic agent vincristine resulting in growth sup-
pression and marked apoptosis (Zhang et al., 1996).
The mechanisms by which Cer causes mitochondrial outer
membrane permeabilization which results in apoptosis are
diverse (reviewed in Siskind (2005)). Remarkably, Cer is able
to permeabilize mitochondrial outer membranes through the
formation of channels that are large enough to allow the egressof IMS proteins into the cytosol (Siskind et al., 2002, 2006;
Stiban et al., 2008). Thus, channel formation by Cer is an
upstream event to the induction of apoptosis (reviewed in
Colombini (2010)). The permeability of the mitochondrial
outer membrane to proteins including cytochrome c can be
increased by the incubation of the isolated mitochondria with
ceramide in a time- and dose-dependent manner (Siskind et al.,
2002). This was the ﬁrst indication that a lipid can form pores
in a biological membrane. Different groups observed similar
effects of ceramide channel formation in protein-free systems
(Siskind and Colombini, 2000; Montes et al., 2002; Pajewski
et al., 2005; Stiban et al., 2006). Increasing evidence (topped
by the visualization of the channels by transmission electron
microscopy (Samanta et al., 2011) demonstrated that a channel
formed by a lipid is possible and valid (Stiban et al., 2008;
Siskind et al., 2003, 2005; Ganesan et al., 2010; Siskind
et al., 2008). Since it is inherently different than a protein chan-
nel, Cer channel formation depends on the steady state level of
Cer in the membrane. Thus, the formation of Cer channels is
controlled mainly by the metabolism of Cer in the membrane.
3. Ceramide biosynthesis
Ceramides are central molecules in sphingolipid synthesis. In
vivo, there are three pathways that lead to the generation of
Cer (Fig. 2). The de novo Cer synthesis pathway starts in the
endoplasmic reticulum (ER) with the condensation of palmi-
toyl-CoA with serine to form 3-ketosphinganine catalyzed by
serine palmitoyl transferase (SPT). The ensuing product is then
reduced by 3-ketosphinganine reductase (KSR) to sphinganine
which is acylated by a family of Cer synthases (CerS) generat-
ing dihydroceramides (DHCer) with varying fatty acyl chain
lengths. In the ﬁnal step of this pathway DHCer desaturase
(DES) facilitates the formation of ceramide inserting a double
bond between C4 and C5 of the sphingoid base. A variety of
evidence suggests that this pathway occurs in the endoplasmic
reticulum (Hirschberg et al., 1993) however, some enzymes
were localized in mitochondria of some cell types (Yu et al.,
2007; Novgorodov et al., 2011) but not others (Stiban et al.,
2008; Mesicek et al., 2010), indicating that this localization
might be cell-type speciﬁc. Even though under normal condi-
tions liver mitochondria were shown to be devoid of DES
activity (Stiban et al., 2008), N-myristoylation targeted the
Figure 2 Ceramide is the hub of sphingolipid metabolism. In the
cell three different pathways produce Cer: the de novo synthesis
from serine and palmitoyl-CoA (top), SM hydrolysis (left) and the
salvage pathway (right). Cer can be used to produce various
simple and complex sphingolipids (bottom). The enzymes used in
those pathways are boxed. SPT: serine palmitoyl transferase;
KSR: 3-ketosphinganine reductase; CerS1-6: ceramide synthases
1–6; DES: dihydroceramide desaturase; SMS: SM synthase;
SMase: sphingomyelinase.
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tosis (Beauchamp et al., 2009), indicating that the localization
of Cer-metabolizing enzymes to the mitochondria is dependent
on cellular conditions as well.
Sphingomyelin (SM) hydrolysis in the plasma membrane
also contributes to the production of ceramide by different iso-
forms of sphingomyelinase (Birbes et al., 2001). SM hydrolysis
has been shown to increase Cer content upon daunorubicin
treatment (Allouche et al., 1997). Another Cer-producing
sequence is the salvage pathway whereby CerS are used to
directly acylate So to form Cer without the need to generate
and desaturate DHCer (Kitatani et al., 2008; Mullen et al.,
2012, 2011).
Thus, a variety of steps can increase Cer contents in cells.
These lipids function differentially in different locations in
the cell. They can form ordered microdomains in the plasma
membrane contributing to signal transduction by receptor pro-
tein aggregation (Silva et al., 2009). They themselves may be
considered second messengers (Becker and Hannun, 2005),
and they can also be responsible for the permeabilization of
mitochondrial outer membranes prior to the initiation of
apoptosis (Birbes et al., 2001).
4. Apoptosis
The term apoptosis (pronounced aepu’tosis) come from the
Greek word for falling off (Kerr et al., 1972). Apoptosis (also
called programed cell death) is the process by which a cell ends
its life without causing inﬂammation as it packages all its con-
tents and sends them to be ingested by neighboring cells (Kerr
et al., 1972; Raff et al., 1994; Hengartner, 2000). There are two
major routes that converge into a common apoptotic pathway
(Fig. 3). Apoptosis can be initiated from signals coming from
outside the cell (extrinsic apoptosis) or from inside the cell
(intrinsic/mitochondrial apoptosis). These signals eventually
induce the permeability of the mitochondrial outer membrane
to cytochrome c and other IMS proteins (Susin et al., 2000).When these proteins are released into the cytosol, other signal-
ing events occur activating the cascade of caspases (cysteine-
aspartic acid proteases) that cleave different nuclear and
cytoplasmic substrates leading to the execution of the cell
(Degterev et al., 2003).
In mitochondrial apoptosis, the permeability of the outer
membrane is enhanced by members of the Bcl-2 family pro-
teins (Cory and Adams, 2002) (such as Bax, Bak and Bad
(Green and Kroemer, 2004), whereas other members of the
same family (Bcl-2, Bcl-xL and Mcl-1 (Zhang et al., 1996;
Nijhawan et al., 2003; Yang et al., 1997; Minn et al., 1999) ren-
der the outer membrane more intact. Hence, the balance
between anti-apoptotic family members and their pro-apop-
totic counterparts can dictate whether or not apoptosis occurs
(Cory and Adams, 2002).
Intrinsic apoptosis is dependent on the increased mitochon-
drial outer membrane permeability (MOMP). Once permeabi-
lized, mitochondria release a number of pro-apoptotic
proteins into the cytosol (mainly, cytochrome c, AIF, Smac/
DIABLO and Omi/HtrA2 (Saelens et al., 2004). In a proliferat-
ing cell, a family of proteins termed IAP (inhibitor of apoptosis)
functions to inhibit the activation of caspases and hence counter
apoptosis. Once Smac/DIABLO is released it blocks IAP and
thus indirectly activates caspases (Vucic et al., 2002).
Moreover, after its release from the IMS cytochrome c binds
toApaf-1 (apoptotic protease-activating factor-1) and this bind-
ing cleaves inactive procaspase-9 into active caspases-9.
Caspase-9 cleaves and hence activates the executioner caspase,
caspase-3 which is the key step for the caspase cascade in intrin-
sic apoptosis (Yang et al., 1997; Liu et al., 1996). Through the
caspase cascade, other proteins and enzymes get activated such
as endonucleases, DNases, proteases and others, and they start
breaking down the cell within their own capacity (e.g. the activa-
tion of caspase-activated DNase (CAD) which degrades DNA
into fragmented ladder is a hallmark of apoptosis (Nagata,
2000)). Also, this cascade activates other caspases which induce
several cytosolic proteins facilitating the formation of the blebs
in the plasmamembrane and causing the rest of themorphologi-
cal changes manifesting in apoptotic cells (Hengartner, 2000).
Previous studies showed that in order for the cell to die by intrin-
sic apoptosis, it must pass by the irreversible step of cytochrome
c release (Susin et al., 2000), but also, the cell must have an active
Apaf-1 in order to die after the release of cytochrome c (Sanchis
et al., 2003).
Morphologically, the apoptotic process occurs in several
steps (Fig. 4): it starts with the condensation of chromatin in
the nucleus, followed by the fragmentation of the nuclear
envelope and DNA hydrolysis by DNases. Moreover, phos-
phatidylserine (a phospholipid normally found exclusively at
the cytosolic side of the plasma membrane bilayer) ﬂips to
the extracellular face of the bilayer (Jacobson et al., 1993,
1994a,b). The cells undergoing apoptosis lose their attachment
to their neighboring cells (Ruoslahti and Reed, 1994), and
blebs (membrane-bound vesicles) form in the plasma mem-
brane accompanied by the shrinkage of the cell (Jacobson
et al., 1993, 1994a,b). Finally, the components of the cell are
packed into membrane-bound bodies called apoptotic bodies
which are endocytosed by macrophages and/or neighboring
cells (Hart et al., 1996).
Despite having different routes that lead to apoptosis, the
process itself is fully regulated (Perry et al., 1996; Degterev
et al., 2003; Raff et al., 1993). Apoptosis often occurs as a
Figure 3 An overview of mechanisms of apoptosis. Apoptosis can be activated extrinsically or intrinsically. In extrinsic apoptosis, a
macrophage carrying a Fas ligand (FasL) binds to Fas receptor (FasR) on the plasma membrane of the cell inducing the trimerization of
the receptor. This induces the recruitment of Fas activated death domain (FADD) which recruits and activates procaspase-8 which
ultimately activates the executioner caspase-3 that is responsible for the activities that lead to apoptosis. On the other hand, intrinsic
apoptosis is centered around mitochondrial outer membrane permeabilization. Different pro-apoptotic proteins reside in the IMS of
mitochondria and when the integrity of the outer membrane is compromised they leak out and cause the activation of apoptosomes, the
condensation of chromatin, membrane blebbing and nuclear envelope destruction. Different proteins affect various steps in both pathways
positively (green arrows) or negatively (red blunt-ended lines). IAP: inhibitor of apoptosis protein; FLIP: (FADD-like IL-1b-converting
enzyme)-inhibitory protein; Smac/DIABLO: second mitochondria-derived activator of caspases/Direct IAP-binding protein with low pI;
HSP 27: heat shock protein 27; Apaf-1: apoptotic protease activating factor 1; Bid and tBid: BH3 interacting domain death agonist and
truncated Bid; Bax: Bcl-2-associated X protein; Bcl-xL: Bcl-2-extra large; EndoG: endonuclease G; Omi/HtrA2: high temperature
requirement A serine endoprotease; AIF: apoptosis-inducing factor; mPTP: mitochondrial permeability transition pore. Note that the
release of all pro-apoptotic proteins from the IMS can be through any one of the shown channels.
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(Wang, 2001); cellular stress (Samali et al., 2010; Fulda
et al., 2010); disruption of calcium homeostasis (Preston
et al., 1997); the closure of the voltage-dependent anion chan-
nel (VDAC) which inhibits the metabolic exchange between
the mitochondria and the cytosol (Lai et al., 2006), etc.
Regardless of the causes, the onset of intrinsic apoptosis is
accompanied by a concomitant increase in mitochondrial Cer
levels (Garcia-Ruiz et al., 1997; Dai et al., 2004). Moreover,
exogenous Cer addition to cells induces apoptosis and DNA
fragmentation (Allouche et al., 1997). The regulation of apop-
tosis is multi-faceted; nevertheless, it is centered around a fam-
ily of proteins, the Bcl-2 family.5. Bcl-2 family proteins
The proliferation and death of cells are tightly regulated by the
cell cycle enzymes and the Bcl-2 family proteins and Tumor
necrosis factors. Some of these proteins interact with
mitochondria and lead to the release of cytochrome c and
apoptosis inducing factors among other proteins. There are
around 20 proteins in Bcl-2 family and they function primarily
as pro- or anti-apoptotic mediators. Pro-apoptotic Bcl-2proteins (such as Bak and Bax) are activated upon cellular
stresses to induce MOMP (Chipuk et al., 2010) by the forma-
tion of pores in mitochondrial outer membrane. Bax, for
instance transports to and restructures at the outer membrane
forming channels (Kim et al., 2009). This breach in mitochon-
drial integrity allows pro-apoptotic proteins to be released
from the IMS and produce the apoptotic response (Green,
2005). Another subset of death-promoting family members is
the BH3-only proteins such as Bid, which aids Bax and Bak
in causing mitochondrial permeability (Dewson et al., 2008).
While most of the family members are pro-apoptotic, six mem-
bers were shown to maintain cell survival and thus exhibiting
anti-apoptotic properties (e.g. Bcl-2, Bcl-xL and Mcl-1)
(Sorenson, 2004). These proteins mainly interfere with the abil-
ity of pro-apoptotic proteins to interact with BH3-only pro-
teins to be activated (Chipuk et al., 2008). It is, therefore,
the ability of the anti-apoptotic proteins to interfere with chan-
nel-formation by pro-apoptotic counterparts that allows for
the regulation of apoptosis induction by Bcl-2 family
(Beverly, 2012). Furthermore, some BH3-only proteins (e.g.
PUMA and Bad) bind and inhibit anti-apoptotic family mem-
bers (Letai et al., 2002; Kuwana et al., 2005).
It is evident that Bcl-2 family proteins are central to the reg-
ulation of the initiation of mitochondrial apoptosis. Since both
Figure 4 Cytology of apoptosis. The different stages of apoptotic cell death start by cellular shrinkage and chromatin condensation,
concomitant with formation of membrane blebs. Organelles and nucleus fragment and the blebs begin formation of apoptotic bodies
which are eventually engulfed by macrophages or neighboring cells by endocytosis/phagocytosis. The lack of release of cellular
components to the extracellular ﬂuid results in the absence of inﬂammation.
764 M. Abou-Ghali, J. StibanBcl-2 family proteins and SLs (particularly Cer) are directly
involved in apoptosis, the relationship between this family
and Cer has been extensively studied (Kawatani et al., 2003;
Zhang and Saghatelian, 2013; Beverly et al., 2013; Jensen
et al., 2014). Their roles in Cer channel formation and
disassembly are discussed below. It is remarkable that the
inhibition of anti-apoptotic Bcl-2 proteins induces C16-Cer
synthesis whereas the exogenous addition of the pro-apoptotic
recombinant Bak potentiated CerS activity in vitro (Beverly
et al., 2013) thus implying other routes of regulation of
apoptosis initiation by Bcl-2 family via Cer production.
6. Ceramide channel formation in mitochondria
The production of Cer in the cell, particularly in mitochondria,
is associated with MOMP permeabilization and apoptosis
initiation (Birbes et al., 2001, 2002; Ghafourifar et al., 1999;
Richter and Ghafourifar, 1999; Di Paola et al., 2004). The
method of permeabilization was a source of debate until
Siskind and Colombini, in the year 2000, pioneered the discov-
ery of the Cer channel in planar phospholipid bilayers (Siskind
and Colombini, 2000) and in isolated mitochondria (Siskind
et al., 2002, 2006). The work was later conﬁrmed by inhibition
assays (Stiban et al., 2006; Elrick et al., 2006), molecular
dynamics simulation (Anishkin et al., 2006) and the visualiza-
tion of these channels by transmission electron microscopy
(Samanta et al., 2011). The biophysics and biochemistry of
Cer channel formation was excellently reviewed by
Colombini (2010, 2013, 2012) and Hage-Sleiman et al. (2013).
Brieﬂy, Cer channels are formed from columns of Cer that
arrange in an anti-parallel fashion making a cylindrical shapespanning the hydrophobic interior of the mitochondrial outer
membrane. Each column is composed of six Cer molecules
(Siskind et al., 2002, 2003; Siskind and Colombini, 2000;
Stiban et al., 2006). Hydrogen bonding, hydrophobic stacking
and dipole–dipole interactions stabilize the columns. The
stacking of Cer columns in a cylindrical barrel-stave channel
is biophysically sound. The hydrogen bonds between the amide
linkages of Cer and underlying carbonyl of another Cer mole-
cule are numerous. In addition, the hydroxyls of the Cer mole-
cule would line up in an ice-lattice-like structure in the lumen of
the channel. Together with dipole–dipole interactions and
hydrophobic stacking, these weak interactions accumulate to
create a stable structure that transverses the hydrophobic part
of the membrane in a water-ﬁlled pathway through which pro-
teins can cross (Colombini, 2010).
Cer channels are dynamic. They grow or shrink by the addi-
tion or removal of Cer columns. The channels can vary in size
depending on the local Cer concentration and the presence of
different proteins that may interact with the channels. Since
the formation and disassembly of these channels is dynamic,
they are severely inﬂuenced by the environment. In this case,
the environment of the channel traverses two phases, the aque-
ous phase in the lumen of the channel and the hydrophobic liq-
uid crystal phase of the bilayer. Hence multiple molecules have
been shown to inﬂuence Cer channels by changing the dynamic
equilibrium in one phase or another.
7. Regulators of ceramide channels
The discovery of lipid channels is novel. The fact that these
channels control a very important aspect of cellular life and
Regulation of ceramide channels 765death is outstanding. Since they control the initiation of apop-
tosis at the point of no return, the induction of MOMP, their
own formation must be regulated extensively. A few inhibitors
were shown to induce channel disassembly in vitro. Some were
metabolites in SL pathways and others were ions and Bcl-2
family proteins (Fig. 5). Here we review inhibitors and stabiliz-
ers of Cer channels.
7.1. Inhibitors
7.1.1. Lanthanum
The ﬁrst inhibitor of Cer channels to be characterized was an
ion: La3+ (Siskind et al., 2003). The effect of La3+ on mem-
branes and channels has been studied for different systems.
Phase transitions (Tanaka et al., 2001; Hammoudah et al.,
1979) and vesicle fusion (Hammoudah et al., 1979) for instance
can be attributed to La3+. Lanthanum ions are known to
block several calcium channels (Grupe et al., 2010; Hoth and
Penner, 1993; Ross and Cahalan, 1995). Similarly, lanthanides
inhibit a wide array of membrane channels such as mechano-
gated channels (Gustin et al., 1988; Lee et al., 1999), VDACFigure 5 A mechanistic view of the action at the mitochondrial out
sequence of events leading to the death of the cell is summarized as follo
via the de novo synthesis pathway. (3) Cer synthesized in the ER is then
sites termed MAM leading to (4) a buildup of Cer in mitochondria. (5
assemble into a barrel-stave channel through which (6) pro-apoptotic p
by DHCer, So, anti-apoptotic Bcl-2 family proteins; and they are poten
release of proteins into the cytosol (7) activates caspases which ultim
channels were obtained from Prof. Marco Colombini at the Universit(Gincel et al., 2001), the voltage-gated sodium channel
(Armstrong and Cota, 1990) and the nonselective cation chan-
nel (Grosman and Reisin, 2000).
It appears that La3+ acts by affecting the ice-lattice-like
hydrogen bonding of the lumen of the channel by interfering
with the hydroxyl, carbonyl and/or amide functional groups
that stabilize the channels (Siskind et al., 2003).
Alternatively, La3+ can induce a shift in the dynamic equilib-
rium between conducting and non-conducting Cer structures
in the membrane favoring structures with a reduced occupied
membrane area (Shao et al., 2012).
7.1.2. Trehalose
Another molecule that disrupts hydrogen bonds in the lumen
of the channel is the disaccharide, trehalose (a-D-glu-
copyranosyl-(1ﬁ 1)-a-D-glucopyranoside). This molecule has
been extensively studied and used as a protecting agent that
maintains the organellar and cytoplasmic structures under
environmental stresses (Wiemken, 1990) such as dehydration
and freezing. It has been used to maintain membrane integrity
in several taxa due to its ability to inﬂuence surroundinger membrane following the activation of intrinsic apoptosis. The
ws: (1) cellular stresses induce (2) the biosynthesis of Cer in the ER
readily imported into mitochondria via ER-mitochondria contact
) The increased local Cer concentration allows those lipids to self-
roteins are released into the cytosol. Those channels are inhibited
tiated by pro-apoptotic Bcl-2 proteins (see the text for details). The
ately (8) induce apoptosis. Note: the structures in black of Cer
y of Maryland College Park.
766 M. Abou-Ghali, J. Stibanhydrogen bonds of water molecules (Block, 2003; Cordone
et al., 2005).
Trehalose inhibits Cer channels in phospholipid membranes
by inducing partial disassembly. This property of trehalose
allowed Colombini and coworkers to distinguish between Cer
channel permeability and that of Bax when bothmolecules were
used together, since activated Bax conductance is insensitive to
trehalose inhibition (Ganesan et al., 2010). It is noteworthy to
mention that sucrose had similar, albeit less prominent, effects
on Cer channels in phospholipid bilayers and in isolated
mitochondria forcing us to switch the buffer used to isolate
mitochondria from a sucrose to a mannitol buffer (data not
shown and Stiban et al., 2006). Working with different Cer ana-
logs to test the hydrogen-bonding requirement for Cer channel
formation, Perera et al. showed that methylation of the C1-hy-
droxyl reduced the hydrogen-bonding capabilities of the mole-
cule and resulted in the formation of transient channels which
were unstable and unable to allow the release of cytochrome c
(Perera, Ganesan et al., 2012). Similarly urea-Cer increased
hydrogen-bonding and therefore formed more channels in the
outer membrane (Perera, Ganesan et al., 2012).
7.1.3. Bovine serum albumin
Early experiments in planar phospholipid membranes identi-
ﬁed albumin as a key inhibitor of C2- but not C16-Cer
permeability (Siskind et al., 2002). BSA is a molecule that
has the ability to carry different hydrophobic compounds such
as free fatty acids, bilirubin, lipid soluble hormones, and some
drugs in the blood (Farrugia, 2010). BSA is therefore able to
extract short chain Cer from the membrane thus lowering
the local Cer concentration in the membrane favoring channel
disassembly. C16-Cer is probably harder to pull from the mem-
brane and hence is unaffected by BSA. Mitochondria treated
with C2-Cer after incubation with BSA showed reduced
MOMP as did mitochondria treated with BSA after C2-Cer
incubation arguing that BSA is able to disassemble Cer chan-
nels as well as to prevent them from forming (Siskind et al.,
2002) by sequestering Cer molecules in its hydrophobic pocket,
away from the membrane. Indeed, BSA was able to remove
C2-Cer from mitochondria as mitochondria treated with
C2-Cer alone had 10-fold excess of Cer in the membrane
compared to when BSA was added. Permeability was increased
5-fold under these circumstances. Thus, the ability of BSA to
reverse MOMP is indeed due to the depletion of Cer from
the membrane (Siskind et al., 2006).
7.1.4. Dihydroceramide
Early experiments in the ﬁeld of SL biology indicated that Cer is
a pro-apoptotic molecule which induces cytochrome c release
into the cytosol whereas DHCer is biologically silent in both
categories (Obeid et al., 1993; Ghafourifar et al., 1999;
Richter and Ghafourifar, 1999). DHCer is not only inactive
in producing an apoptotic response, but also inhibitory to
Cer MOMP and apoptosis induction, as both C2- and C16-
Cer channels were inhibited by C2- and C16-DHCer, respec-
tively (Stiban et al., 2006). As noted previously, the de novo syn-
thesis produces DHCer by the action of different CerS which
are then desaturated by different isoforms of DES to produce
Cer. DES is an ER-bound enzyme under normal conditions
(Stiban et al., 2008) but it can be targeted to mitochondria upon
N-myristoylation (Beauchamp et al., 2009). Only the wild-typemyristoylable DES1-Gly (and not the unmyristoylable mutant
DES1-Ala), induced apoptosis of COS-7 cells (Beauchamp
et al., 2009). MOMP was signiﬁcantly enhanced upon supple-
menting mitochondria with DHCer and NADPH (both sub-
strates of the mixed-function oxidase DES) compared to
supplementing them with only one of the substrates. In addi-
tion, mixing microsomal membranes supplemented with
DHCer and NADPH with ER mitochondrial preparations
enhanced MOMP indicating that Cer produced in the ER is
readily transferrable to mitochondria via contact sites termed
mitochondrial associated membranes (MAM) Stiban et al.,
2008. DHCer, due to its saturated C4 and C5, is able to interfere
with the strict packing of Cer molecules in the columns making
the channel. Thus 1 part in 10 of DHCer was able to induce Cer
channel disassembly, makingDHCer a strong antagonist of Cer
channel dynamics. The trans double bond is therefore crucial
for channel formation. The formation and stability of Cer chan-
nels were enhanced when using Cer containing an additional
trans double bond in a position allowing for p resonance
between the two bonds (Perera, Ganesan et al., 2012). The
mode of inhibition is therefore biophysical and is due to the
intercalation of DHCer molecules within Cer columns which
is destabilizing.
Biologically, there are many implications for this DHCer
inhibition of Cer channel formation in vivo. In cells lacking
DES, Cer was not produced and the cells were larger with
respect to wild-type controls and resistant to apoptosis.
Moreover, strong activation of the anti-apoptotic and anabolic
signaling pathway regulated by Akt/protein kinase B was
observed in these cells (Siddique et al., 2013). The ablation
of DES also protected cells from etoposide-induced apoptosis
(Siddique et al., 2012). Furthermore, mitochondrial depolar-
ization and late-apoptosis were reduced by DES knockdown
and the pro-apoptotic effects of Cer were signiﬁcantly reduced
by DHCer (Breen et al., 2013). These results highlight the
effects of DHCer on Cer channel formation and the onset of
apoptosis and identify DES as a potential therapeutic target
for a variety of diseases.
Even thoughDHCer does not induceMOMPor apoptosis, it
is indeed a biologically active molecule with different character-
istics from its Cer relatives (Rodriguez-Cuenca et al., 2015). In
obesity, for instance, it was shown that pharmacological inhibi-
tion of DES prevents adipocyte differentiation; on the other
hand obese patients exhibited lower expression of the gene
encoding DES in their adipose tissue indicating that DHCer
to Cer conversion is essential and that the accumulation of
DHCer is associated with other biological functions
(Barbarroja et al., 2014). Moreover, in the hypoxic heart, total
Cer levels increased then decreased sharply concomitant with
an increase in DHCer levels in the right ventricle (Noureddine
et al., 2008) due to the repression of DES gene (Azzam et al.,
2013). All these data conﬁrm the signiﬁcance of the switch from
unsaturatedDHCer tomonounsaturatedCer in a variety of bio-
logical scenarios including Cer channel formation.
7.1.5. Sphingosine
Another precursor of Cer is the amino alcohol So. Different
CerS can N-acylate So to form Cer in the salvage pathway.
Unlike DHCer, So is another lipid that can form channels in
membranes (Siskind et al., 2005). However, like DHCer, it
has the capability to disassemble Cer channels (Elrick et al.,
Regulation of ceramide channels 7672006). The intercalation of So with Cer columns is probably
destabilizing since those lipids may be incompatible. As pre-
viously noted, Cer channels are dynamic: there is a constant
insertion on more columns and/or removal of other columns
resulting in the enlargement or contraction of the channel.
There is a dynamic equilibrium between Cer columns in the
channel and non-conducting structures in the membrane. In
the case of So, similar to DHCer, the interaction between this
molecule and Cer columns seems to be destabilizing the struc-
ture of the channel leading to disassembly. Despite the fact
that both lipids form channels with some order in the mem-
brane, their combination may result in instability due to poorly
organized hybrid structures (Colombini, 2013).
7.1.6. Very long chain ceramides
Cer with different fatty acyl chains permeabilize mitochondria
differentially. They all form channels in mitochondrial outer
membranes as well as in artiﬁcial membranes. Recently we
showed that similar results were obtained with different Cer
species inhibiting each other’s ability to form channels.
Indeed C24-Cer inhibited C16-Cer channel formation and vice
versa in liposomes and mitochondria (Stiban and Perera,
2015). The notion of instability of the combination of mole-
cules is valid in this case as well. Using several biophysical
techniques, it was shown by Silva and colleagues that Cer with
different fatty acyl chain lengths affect properties of phospho-
lipid membranes differently (Pinto et al., 2011, 2014), in agree-
ment with previous results exhibiting the biophysical
properties of membranes formed from microsomes lacking
very long chain sphingolipids (Silva et al., 2012). In vitro
experiments with protein-free liposomes showed a biphasic
effect of permeability when titrating C16-Cer with C22-Cer.
As C16-Cer was decreased and C22-Cer was increased, liposo-
mal permeability was ﬁrst inhibited then returned to the start-
ing level indicating that different channels were formed and
that both Cer species interfered with the channels formed by
the other. This was also observed in isolated mitochondria
(Stiban and Perera, 2015).
This interplay between Cer species with different acyl chains
indeed has severe implications in SL biology. There are 6 mam-
malian isoforms of CerS each of which catalyzing the acylation
of the sphingoid base with speciﬁc subsets of fatty acyl chains
(Stiban et al., 2010). Different CerS enzymes undergo homo-
or heterodimerization as a regulatory mechanism (Laviad
et al., 2012) affecting the products of these enzymes. This bio-
physical inhibition of Cer channel formation by different Cer
species adds to the complexity of when and where permeabiliza-
tion may occur. In colon cancer cells, co-overexpression of
CerS2 (responsible for producing very long chain ceramides)
with CerS4 (C18-Cer) or CerS6 (C16-Cer) increased the total
Cer levels but did not result in cell death indicating that the abil-
ity to instruct cells to start apoptosis depends on the equilibrium
between the various Cer species in biological membranes
(Hartmann et al., 2013). Moreover, in a variety of neurode-
generative diseases, different subsets of Cer and different CerS
enzymes are activated or inhibited, further showing that the
chain length is an extremely important functional feature of
Cer (Ben-David and Futerman, 2010).
Very long chain Cer species have key roles in cells. CerS2
null mice are unable to synthesize very long chain Cer and
SLs and exhibit glucose intolerance as insulin signaling is
altered in the liver. In hepatocytes of CerS2 null mice, insulinreceptor is unable to translocate to lipid microdomains to initi-
ate insulin response, as those microdomains differ signiﬁcantly
from wild-type mice due to their lack of very long chain Cer
(Park et al., 2013). The disequilibrium of Cer carrying different
chain lengths was proposed to be important for cancer pro-
gression whereas normal cells have equilibrium between sev-
eral Cer species (Hartmann et al., 2012).
7.1.7. Anti-apoptotic Bcl-2 proteins
Apoptosis is regulated mainly by Bcl-2 family proteins
(Chipuk et al., 2010, 2008; Sorenson, 2004). The effects of
anti-apoptotic Bcl-2 proteins (e.g. the mammalian Bcl-xL
and Caenorhabditis elegans CED-9) on Cer-induced MOMP
were thoroughly investigated. Both anti-apoptotic proteins
inhibited Cer channel formation in isolated mitochondria
and were able to reverse the permeabilization, presumably by
favoring channel disassembly (Siskind et al., 2008). Even
though other pro-apoptotic proteins are present in isolated
mitochondria and there is a possibility that Bcl-xL interferes
with them and hence inﬂuences Cer indirectly, almost identical
results were obtained using mitochondria isolated from the
yeast Saccharomyces cerevisiae. This particular yeast strain is
devoid of proteins homologous to those of the Bcl-2 family.
Thus both Bcl-xL and CED-9 are interfering directly with
the ability of Cer to cause MOMP. Moreover, overexpression
of Bcl-2 in yeast resulted in mitochondria that were resistant to
Cer permeabilization (Siskind et al., 2008). Furthermore, in the
protein-free system of planar membranes formed from pure
phospholipids and cholesterol, both CED-9 and Bcl-xL were
shown to disassemble Cer-induced conductances arguing that
the action of Bcl-xL is directly on the Cer channel (Siskind
et al., 2008).
Using a variety of Cer analogs, it was demonstrated that
Bcl-xL preferentially binds the aliphatic hydrocarbon chains
in Cer (Perera, Lin et al., 2012). Bcl-xL interferes with Cer
channel formation optimally when the Cer used has C16- or
C18- fatty acyl side chain. This interference is markedly
reduced when using Cer with longer or shorter chains
(Perera, Lin et al., 2012). Mutant Bcl-xL protein which is
not anti-apoptotic did not reduce the MOMP by Cer
(Siskind et al., 2008) hence the effect of Bcl-xL is protein-
and lipid-speciﬁc. Furthermore, neither SM hydrolysis nor
Cer generation was affected by Bcl-2 overexpression in leuke-
mia cells even though this overexpression protected the cells
from undergoing apoptosis; therefore, the protection by Bcl-
2 of apoptosis downstream to Cer generation (Allouche
et al., 1997) in agreement with a direct effect of anti-apoptotic
Bcl-2 family proteins of Cer channel itself.
7.2. Stabilizers: pro-apoptotic Bcl-2 proteins
Naturally, the effects of pro-apoptotic Bcl-2 family proteins
are the opposite to those of their anti-apoptotic family mem-
bers. Some pro-apoptotic Bcl-2 family proteins work by
permeabilizing the mitochondrial outer membrane. Activated
Bax is able to permeabilize mitochondria without the need of
Cer. On the other hand, Cer is able to cause MOMP in cells
deﬁcient of Bax or Bak as well as in protein-free membranes.
However, treating isolated mitochondria with both activated
Bax and Cer, for instance, induced a higher level of permeabi-
lization than either treatment alone, in synergy (Ganesan et al.,
768 M. Abou-Ghali, J. Stiban2010). Bax and Cer were also reported to act synergistically in
irradiated HeLa cells to facilitate MOMP and cytochrome c
release (Lee et al., 2011). Synergy was also reported between
Bax and Cer in inducing mtPTP (Pastorino et al., 1999). As
opposed to Bcl-xL, Bax binds at a different region of the
Cer channel as it preferentially binds Cer at the amide nitro-
gen. When this nitrogen is blocked by methylation the interac-
tion is lost (Perera, Lin et al., 2012). Activated Bax is thought
to be a scaffolding protein on which Cer channel is driven to a
speciﬁc radius of curvature (Colombini, 2013). In this sense,
Bax is functioning as a Cer channel stabilizer and the synergy
is contingent on Cer domains aiding in Bax oligomerization
and Bax stabilizing Cer channel.
So far, Bax is the sole molecule that has been reported to
stabilize Cer channels in vitro. We expect more proteins to fol-
low suit, as stabilization of the channel is required for a sus-
tained response to initiate apoptosis. Another pro-apoptotic
Bcl-2 protein, Bak, was recently shown to enhance Cer produc-
tion upon UV-C irradiation, cisplatin or growth factor with-
drawal. This enhancement was due to the activation of CerS
by Bak and not Bax (Siskind et al., 2010). Thus it is striking
to observe that Bax and Bak (which are considered to be
redundant proteins) operate via two very different mechanisms
pertaining interaction with Cer metabolism in vivo.
8. Conclusion and future directions
In this brief review the role of Cer in the initiation of apoptosis
was probed, particularly its ability to form channels in
mitochondrial outer membranes. The relationship between
Cer, Cer metabolism, Cer channels, and Bcl-2 family proteins
was also discussed in light of new and exciting data. Apoptosis
is an elaborate process that requires intricate networks of
molecules working together to produce a timely response.
Mitochondrial apoptosis is contingent on MOMP. There are
multiple proposed mechanisms for the pathway through the
outer membrane that allows IMS proteins to be released to
initiate apoptosis. Due to the complex nature of apoptosis, it
is unlikely that the method of IMS proteins release is solitary.
In vivo there are a plethora of signaling molecules, signaling
events and cascades that need to be coordinated in order to
achieve the ultimate goal of killing the cell without harming
the surrounding neighbors. Pro-apoptotic Bcl-2 family pro-
teins form a water-ﬁlled pathway in the outer membrane, but
so does Cer. Both molecules are therefore involved in
MOMP directly. The regulation of Cer channel formation
and disassembly is an established ﬁeld now. It is therefore a
challenge lying ahead to identify different inhibitors or Cer
channels in vitro as well as in vivo whether or not these mole-
cules are members of Bcl-2 family. Furthermore, the coordina-
tion of Cer channels with other outer membrane channels may
be probed to identify other synergistic effects of membrane
Cer.
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